Literature DB >> 2501515

In vitro processing of dengue virus structural proteins: cleavage of the pre-membrane protein.

L Markoff1.   

Abstract

Processing of dengue virus structural proteins was assessed in vitro. RNA transcripts for cell-free translation were prepared from cloned DNA (dengue virus type 4, strain 814669 genome) encoding capsid, pre-membrane (prM), and the first 23 amino acids of envelope (E). Processing of a 33-kilodalton precursor polypeptide encoded by wild-type RNA transcripts occurred only in the presence of added microsomal membranes. Under these conditions, cleavage at the capsid-prM and prM-E sites and glycosylation of prM occurred in association with translocation. Amino acid sequence analysis confirmed that translation initiated at the predicted N terminus of the capsid and that capsid-prM cleavage occurred at the predicted site for the action of signal peptidase following a candidate signal sequence (hydrophobic residues 100 to 113) in the dengue virus precursor. Mutations were introduced into the dengue virus DNA template by site-directed mutagenesis, altering nucleotide sequences encoding the capsid and the candidate signal for prM. The phenotypes of the mutants were deduced by analysis of the products of cell-free translation of the respective RNA transcripts. The resulting observations confirmed that cleavage at the capsid-prM and prM-E sites is effected entirely by signal peptidase and that the candidate signal is required for translocation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2501515      PMCID: PMC250908     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Dengue virus identification by the plaque reduction neutralization test.

Authors:  P K Russell; A Nisalak
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

2.  Studies on virus-specific nucleic acids synthesized in vertebrate and mosquito cells infected with flaviviruses.

Authors:  G Wengler; G Wengler; H J Gross
Journal:  Virology       Date:  1978-09       Impact factor: 3.616

3.  Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors.

Authors:  M J Zoller; M Smith
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  Synthesis of glycoproteins in cells infected by the flavivirus Kunjin.

Authors:  P J Wright; H M Warr; E G Westaway
Journal:  Virology       Date:  1981-03       Impact factor: 3.616

5.  Amino acid sequence of the heavy chain of bovine protein C.

Authors:  J Stenflo; P Fernlund
Journal:  J Biol Chem       Date:  1982-10-25       Impact factor: 5.157

6.  Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elements.

Authors:  J J Dunn; F W Studier
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

7.  Translation of tick-borne encephalitis virus (flavivirus) genome in vitro: synthesis of two structural polypeptides.

Authors:  Y V Svitkin; T Y Ugarova; T V Chernovskaya; V N Lyapustin; V A Lashkevich; V I Agol
Journal:  Virology       Date:  1981-04-15       Impact factor: 3.616

8.  Comparisons of togaviruses: Sindbis virus (group A) and Kunjin virus (group B).

Authors:  R W Boulton; E G Westaway
Journal:  Virology       Date:  1972-07       Impact factor: 3.616

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  The role of the hydroxy amino acid in the triplet sequence Asn-Xaa-Thr(Ser) for the N-glycosylation step during glycoprotein biosynthesis.

Authors:  E Bause; G Legler
Journal:  Biochem J       Date:  1981-06-01       Impact factor: 3.857

View more
  35 in total

1.  Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing.

Authors:  S M Amberg; C M Rice
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles.

Authors:  Beate M Kümmerer; Charles M Rice
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  Mutational analysis of the octapeptide sequence motif at the NS1-NS2A cleavage junction of dengue type 4 virus.

Authors:  M Pethel; B Falgout; C J Lai
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

4.  Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins.

Authors:  B Falgout; M Pethel; Y M Zhang; C J Lai
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

5.  Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis.

Authors:  M Hijikata; N Kato; Y Ootsuyama; M Nakagawa; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

6.  Processing of dengue virus type 2 structural proteins containing deletions in hydrophobic domains.

Authors:  A Gruenberg; P J Wright
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

7.  Expression of the structural proteins of dengue 2 virus and yellow fever virus by recombinant vaccinia viruses.

Authors:  Y S Hahn; E M Lenches; R Galler; C M Rice; J Dalrymple; J H Strauss
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

8.  NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies.

Authors:  S M Amberg; A Nestorowicz; D W McCourt; C M Rice
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Selenomethionine incorporation into a protein by cell-free synthesis.

Authors:  Takanori Kigawa; Emi Yamaguchi-Nunokawa; Koichiro Kodama; Takayoshi Matsuda; Takashi Yabuki; Natsuko Matsuda; Ryuichiro Ishitani; Osamu Nureki; Shigeyuki Yokoyama
Journal:  J Struct Funct Genomics       Date:  2002

10.  Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus.

Authors:  Ruhe Men; Tetsu Yamashiro; Ana P Goncalvez; Claire Wernly; Darren J Schofield; Suzanne U Emerson; Robert H Purcell; Ching-Juh Lai
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.